Anavex Life Sciences
AVXL
#7563
Rank
HK$3.06 B
Marketcap
HK$34.25
Share price
-1.12%
Change (1 day)
-42.08%
Change (1 year)

Revenue for Anavex Life Sciences (AVXL)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Anavex Life Sciences from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ligand Pharmaceuticals
LGND
HK$1.95 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$4.66 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$5.76 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA